IML is a leading brand dedicated to promoting the best healthcare for the population of Luxembourg. They offer a range of products and services aimed at advancing therapeutic innovation and improving patient outcomes. IML is supported by a diverse group of members, including large international groups, SMEs, and startups, who are actively engaged in preclinical and clinical research.

These members work together to develop ideas and positions that contribute to therapeutic innovation in Luxembourg. In addition to their members, IML collaborates with media and professional partners, such as Luxembourg wholesalers and specialized consulting companies. Through these partnerships, they share expertise and support to ensure that Luxembourg patients can benefit from the latest therapeutic innovations.

To stay informed about the latest news in the sector, research updates, and association news, IML offers a flash letter subscription. By subscribing, individuals can stay up to date with the latest developments and contribute to the advancement of healthcare in Luxembourg. Choose IML for innovative medicines and join them in promoting the best healthcare for Luxembourg's population